Process for evaluating skin care product efficacy and skin care product efficacy evaluation system

• US 10,073,945 B1
• Filed: 05/06/2016
• Issued: 09/11/2018
• Est. Priority Date: 05/06/2015
• Status: Active Grant

• Current Assignee: Hualin Huang, Ning Pan
• Original Assignee: Hualin Huang, Ning Pan
• Inventors: Pan, Ning, Huang, Hualin
• Primary Examiner(s): Desta, Elias
• Application Number:
  US15/149,000
• Time in Patent Office: 858 Days
• CPC Class Codes: A61K 8/00 Cosmetics or similar toiletry preparations
• CPC Class Codes: G01N 33/4833 of solid biological material, e.g. tissue samples, cell cultures tissue in vivo A61B5/00; cell suspensions G01N33/48735
• CPC Class Codes: G16B 5/00 ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks

Abstract

An instrumental approach enabling evaluation of efficacy of skin care products is disclosed. Common problems shared by existing methods include first the difficulty whether to test the entire human face, or just focus on the key locations (not determined yet); the difficulty in conducting a repeatable test when human face is hard to fix on and changes between different persons; and how many different skin attributes to test for making a reliable and complete judgment. The instrumental approach of the process tests a sample at once to obtain all the information needed. It shows good repeatability and sensitivity. It yields necessary yet sufficient information in numbers.

Claims

1. A system to objectively evaluate the efficacy of a skin care product, said system comprising:

a first sample membrane treated with a skin care product;

a second sample membrane with no skin care product applied;

a phabrometer comprising a transducer, a pushing rod, and a pressure plate; and

a data computation and display system comprising a computer screen and a computerized smart machine that includes a processor, a memory storage, and a program that is stored in the memory storage and which, when running on the processor of the computerized smart machine, evaluates the efficacy of the skin care product, said program comprising sets of instructions for (i) creating a skin care product efficacy test project to record sets of membrane attribute data resulting from a first phabrometer-based test of the first sample membrane with the skin care product applied and a second phabrometer-based test of the second sample membrane with no skin care product applied, (ii) configuring a set of test condition settings that defines a scope of testing by the phabrometer for each of the first phabrometer-based test of the first sample membrane and the second phabrometer-based test of the second sample membrane, (iii) capturing a first set of membrane attribute data while the phabrometer performs the first phabrometer-based test of the first sample membrane with the skin care product applied, (iv) calculating an efficacy value for each membrane attribute in the first set of membrane attribute data, (v) capturing a second set of membrane attribute data while the phabrometer performs the second phabrometer-based test of the second sample membrane without the skin care product applied, (vi) calculating baseline value for each membrane attribute in the second set of membrane attribute data, and (vii) displaying a set of skin care product efficacy charts on the computer screen that demonstrate the efficacy of the skin care product in comparison with no skin care product.

2. The system of claim 1, wherein each set of membrane attribute data corresponds to a set of skin attributes.

3. The system of claim 2, wherein the set of skin attributes comprise skin softness, skin smoothness, skin resilience, and wrinkle recovery.

4. The system of claim 3, wherein the set of instructions for displaying a set of skin care product efficacy charts on the computer screen comprises a set of instructions for displaying a skin softness efficacy chart comprising a first graphical element with a size that corresponds to the calculated efficacy value for the skin softness membrane attribute and a second graphical element with a size that corresponds to the calculated baseline value for the skin softness membrane attribute.

5. The system of claim 3, wherein the set of instructions for displaying a set of skin care product efficacy charts on the computer screen comprises a set of instructions for displaying a skin smoothness efficacy chart comprising a first graphical element with a size that is weighted according to the calculated efficacy value for the skin smoothness membrane attribute and a second graphical element with a size that is weighted according to the calculated baseline value for the skin smoothness membrane attribute.

6. The system of claim 3, wherein the set of instructions for displaying a set of skin care product efficacy charts on the computer screen comprises a set of instructions for displaying a skin resilience efficacy chart comprising a first graphical element with a size that is weighted according to the calculated efficacy value for the skin resilience membrane attribute and a second graphical element with a size that is weighted according to the calculated baseline value for the skin resilience membrane attribute.

7. The system of claim 3, wherein the set of instructions for displaying a set of skin care product efficacy charts on the computer screen comprises a set of instructions for displaying a wrinkle recovery efficacy chart comprising a first graphical element with a size that is weighted according to the calculated efficacy value for the wrinkle recovery membrane attribute and a second graphical element with a size that is weighted according to the calculated baseline value for the wrinkle recovery membrane attribute.

8. A non-transitory computer readable medium storing a program which, when executed by a processor of a computing device embedded in a phabrometer smart machine, evaluates the efficacy of a plurality of skin care products by way of a phabrometer that tests a sample membrane for each of the plurality of skin care products, said program comprising sets of instructions for:

creating a skin care product efficacy test project to record sets of membrane attribute data resulting from phabrometer-based tests of a plurality of sample membranes with the plurality of skin care products applied, wherein each skin care product in the plurality of skin care products is applied to only one sample membrane in the plurality of sample membranes;

configuring a set of test condition settings that defines a scope of testing by the phabrometer for the phabrometer-based tests of the plurality of sample membranes;

providing the set of test condition settings to the processor of the computing device embedded in the phabrometer smart machine to set runtime configuration for testing the plurality of sample membranes;

directing the phabrometer smart machine, by the computing device, to sequentially test the plurality of sample membranes, wherein each successive sample membrane is tested, by the phabrometer smart machine, by capturing a set of membrane attribute data for the sample membrane and calculating, by the computing device, an efficacy value for each membrane attribute of the sample membrane; and

displaying, on a computer screen communicably connected to the computing device, a set of skin care product efficacy charts that compare the efficacy of the plurality of skin care products for each set of membrane attribute data.

9. The non-transitory computer readable medium of claim 8, wherein each set of membrane attribute data corresponds to a set of skin attributes comprising skin softness, skin smoothness, wrinkle recovery, and skin resilience.

10. The non-transitory computer readable medium of claim 9, wherein the set of instructions for displaying, on the computer screen communicably connected to the computing device, a set of skin care product efficacy charts comprises sets of instructions for:

displaying, on the computer screen communicably connected to the computing device, a skin softness efficacy chart comprising a plurality of skin softness graphical elements corresponding to the plurality of skin care products, each skin softness graphical element having a size that is weighted according to the calculated efficacy value of a skin softness membrane attribute for the captured set of membrane attribute data of the sample membrane with the corresponding skin care product applied;

displaying, on the computer screen communicably connected to the computing device, a skin smoothness efficacy chart comprising a plurality of skin smoothness graphical elements corresponding to the plurality of skin care products, each skin smoothness graphical element having a size that is weighted according to the calculated efficacy value of a skin smoothness membrane attribute for the captured set of membrane attribute data of the sample membrane with the corresponding skin care product applied;

displaying, on the computer screen communicably connected to the computing device, a wrinkle recovery efficacy chart comprising a plurality of wrinkle recovery graphical elements corresponding to the plurality of skin care products, each wrinkle recovery graphical element having a size that is weighted according to the calculated efficacy value of a wrinkle recovery membrane attribute for the captured set of membrane attribute data of the sample membrane with the corresponding skin care product applied; and

displaying, on the computer screen communicably connected to the computing device, a skin resilience efficacy chart comprising a plurality of skin resilience graphical elements corresponding to the plurality of skin care products, each skin resilience graphical element having a size that is weighted according to the calculated efficacy value of a skin resilience membrane attribute for the captured set of membrane attribute data of the sample membrane with the corresponding skin care product applied.